Details for Patent: 5,912,013
✉ Email this page to a colleague
Summary for Patent: 5,912,013
Title: | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
Abstract: | The present invention relates to a composition and method of treating a patient by administering carbamazepine in a pharmaceutical dosage form capable of maintaining the patient's blood concentration at from about 4 .mu.g/ml to about 12 .mu.g/ml over at least a 12 hour period, where the blood concentration of carbamazepine does not vary by more than 60 percent. |
Inventor(s): | Rudnic; Edward M. (North Potomac, MD), Belendiuk; George W. (Potomac, MD), McCarty; John (Biscayne Park, FL), Wassink; Sandra (Frederick, MD), Couch; Richard A. (Germantown, MD) |
Assignee: | Shire Laboratories, Inc. (Rockville, MD) |
Application Number: | 08/426,394 |
Patent Claim Types: see list of patent claims | Composition; |
Drugs Protected by US Patent 5,912,013
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,912,013
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 185268 | ⤷ Sign Up | |||
Canada | 2114014 | ⤷ Sign Up | |||
Germany | 69230112 | ⤷ Sign Up | |||
Denmark | 0660705 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |